These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11128638)

  • 1. 6-Hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors.
    Lee YS; Lee YS; Lee JY; Kim SN; Lee CK; Park H
    Bioorg Med Chem Lett; 2000 Dec; 10(23):2625-7. PubMed ID: 11128638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease.
    Min BS; Jung HJ; Lee JS; Kim YH; Bok SH; Ma CM; Nakamura N; Hattori M; Bae K
    Planta Med; 1999 May; 65(4):374-5. PubMed ID: 10364847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-HIV derivatives: synthesis and antiviral evaluation.
    De Michelis C; Rocheblave L; Priem G; Chermann JC; Kraus JL
    Bioorg Med Chem; 2000 Jun; 8(6):1253-62. PubMed ID: 10896105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
    Wei Y; Ma CM; Hattori M
    Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands.
    Chen X; Kempf DJ; Sham HL; Green BE; Molla A; Korneyeva M; Vasavanonda S; Wideburg NE; Saldivar A; Marsh KC; McDonald E; Norbeck DW
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3531-6. PubMed ID: 9934466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir).
    Sham HL; Betebenner DA; Herrin T; Kumar G; Saldivar A; Vasavanonda S; Molla A; Kempf DJ; Plattner JJ; Norbeck DW
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1351-3. PubMed ID: 11378352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors.
    Thaisrivongs S; Janakiraman MN; Chong KT; Tomich PK; Dolak LA; Turner SR; Strohbach JW; Lynn JC; Horng MM; Hinshaw RR; Watenpaugh KD
    J Med Chem; 1996 Jun; 39(12):2400-10. PubMed ID: 8691434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.
    Spaltenstein A; Almond MR; Bock WJ; Cleary DG; Furfine ES; Hazen RJ; Kazmierski WM; Salituro FG; Tung RD; Wright LL
    Bioorg Med Chem Lett; 2000 Jun; 10(11):1159-62. PubMed ID: 10866371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tricyclic ureas: a new class of HIV-1 protease inhibitors.
    Han W; Pelletier JC; Hodge CN
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3615-20. PubMed ID: 9934481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From SAR to comparative QSAR: role of hydrophobicity in the design of 4-hydroxy-5,6-dihydropyran-2-ones HIV-1 protease inhibitors.
    Bhhatarai B; Garg R
    Bioorg Med Chem; 2005 Jun; 13(12):4078-84. PubMed ID: 15911321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of di- and tripeptide analogues containing alpha-ketoamide as a new core structure for inhibition of HIV-1 protease.
    Sheha MM; Mahfouz NM; Hassan HY; Youssef AF; Mimoto T; Kiso Y
    Eur J Med Chem; 2000 Oct; 35(10):887-94. PubMed ID: 11121614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel conformationally restricted HIV protease inhibitors.
    Salituro FG; Baker CT; Court JJ; Deininger DD; Kim EE; Li B; Novak PM; Rao BG; Pazhanisamy S; Porter MD; Schairer WC; Tung RD
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3637-42. PubMed ID: 9934485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of triterpene-azidothymidine conjugates on proliferation of human immunodeficiency virus type 1 and its protease.
    Ma CM; Nakamura N; Hattori M; Kawahata T; Otake T
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):877-80. PubMed ID: 12045355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease.
    Kazmierski WM; Furfine E; Spaltenstein A; Wright LL
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3431-3. PubMed ID: 12419377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and clinical development of HIV-1 protease inhibitors.
    Huff JR; Kahn J
    Adv Protein Chem; 2001; 56():213-51. PubMed ID: 11329855
    [No Abstract]   [Full Text] [Related]  

  • 16. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
    Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors.
    Thaisrivongs S; Romero DL; Tommasi RA; Janakiraman MN; Strohbach JW; Turner SR; Biles C; Morge RR; Johnson PD; Aristoff PA; Tomich PK; Lynn JC; Horng MM; Chong KT; Hinshaw RR; Howe WJ; Finzel BC; Watenpaugh KD
    J Med Chem; 1996 Nov; 39(23):4630-42. PubMed ID: 8917652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition.
    Judd DA; Nettles JH; Nevins N; Snyder JP; Liotta DC; Tang J; Ermolieff J; Schinazi RF; Hill CL
    J Am Chem Soc; 2001 Feb; 123(5):886-97. PubMed ID: 11456622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of selenazole-substituted ritonavir analogs.
    Qiao J; Zhao C; Liu J; Du Y
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2379-2381. PubMed ID: 29934245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.